Network Meta-Analysis Across Longitudinal Time Points: A Comparison of Available Methods (English)
- New search for: Tallarita, M
- New search for: de Iorio, M
- New search for: Baio, G
- New search for: Karabis, A
- New search for: Tallarita, M
- New search for: de Iorio, M
- New search for: Baio, G
- New search for: Karabis, A
In:
Value in health
;
19
, 7
;
A394
;
2016
-
ISSN:
- Article (Journal) / Print
-
Title:Network Meta-Analysis Across Longitudinal Time Points: A Comparison of Available Methods
-
Contributors:
-
Published in:Value in health ; 19, 7 ; A394
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2016-01-01
-
Size:A394
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610.28
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610.28 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 19, Issue 7
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- A347
-
Aligned and Flexible? A Comparative Review of SMC and Nice Decision-MakingJohnson, H. / Spoors, J. / Johnson, J. et al. | 2016
- A347
-
Considering or Not Adverse Events in Health Economic Models: A Pragmatic ApproachRoze, S. / Cartier-Bechu, C. / Gherardi, A. / Monnier, R. / Pignata, M. / Petijean, A. / Sivignon, M. et al. | 2016
- A347
-
The Impact of Extrapolating Survival Based on Cure Models: Comparing Mean Incremental Survival and Cure Rates in Different Datasetsvan Oostrum, I. / Postma, M. / Buskens, E. / Heeg, B. et al. | 2016
- A347
-
The Impact of Dynamic Transmission Modelling on the Estimated Cost-Effectiveness of Treatment for Chronic Hepatitis C in The United KingdomMadin-Warburton, M. / Pitcher, A. / Martin, N. et al. | 2016
- A347
-
Achieving Optimal Fit-To-Survival Data Using Cubic Spline Models: A Case-Study Comparing The Fit of Standard and Cubic Spline Models to Survival Data from the Icon6 StudyHettle, R. / Sackeyfio, A. / Suri, G. et al. | 2016
- A348
-
Actuarial Approaches To Modelling and Mitigating Financial Uncertainty in Recommending New Drugs and Health TechnologiesBuckle, J. / Serre, D. et al. | 2016
- A348
-
A Meta Regression Analysis of Utility Weights for Breast CancerGong, J. / Lim, J. / Bae, S. et al. | 2016
- A348
-
Utility By Treatment Line In Multiple Myeloma; Analysis of Over 9000 EQ-5Q-3L Questionnaires from the Emmos RegistryHatswell, A. / Couturier, C. / Ito, T. et al. | 2016
- A348
-
Prospective Utility Study of Patients with Multiple Cardiovascular EventsPockett, R. / McEwan, P. / Ray, J. / Tran, I. / Shutler, S. / Martin, S. / Yousef, Z. / Bakhai, A. et al. | 2016
- A348
-
A Review of the Use of Network Meta-Analysis In Nice Single Technology AppraisalsFleetwood, K. / Glanville, J. / McCool, R. / Wood, H. / Wilson, K. / Marshall, C. / Yellowlees, A. / James, D. / Toupin, S. / McCabe, R. et al. | 2016
- A348
-
Implementation of Conditional Reimbursement Schemes in HTA Practice: Experiences from the NetherlandsMakady, A. / Nijmeijer, H. / de Boer, A. / Hillege, J. / Klungel, O. / Goettsch, W. et al. | 2016
- A349
-
Policy Objective of Generic Medicines from the Investment Perspective: The Case of ClopidogrelElek, P. / Harsányi, A. / Zelei, T. / Csetneki, K. / Kaló, Z. et al. | 2016
- A349
-
Are Component Endpoints Equal? A Study into the Practice of Composite End Points in Clinical TrialsVaanholt, M. / von Birgelen, C. / Kok, M. / Weernink, M. / van Til, J. et al. | 2016
- A349
-
Using Subpopulation Treatment Effect Pattern Plot to Identify More Efficient Resource Allocation PoliciesCao, Q. / Hillege, J. / Postma, M. / Buskens, E. / Postmus, D. et al. | 2016
- A349
-
Mapping Quality of Life Scores from FACT-G, FAACT And FACIT-F Onto Preference-Based Utilities Using the 5-Level Version of EQ-5D QuestionnaireMeregaglia, M. / Borsoi, L. / Cairns, J. / Tarricone, R. et al. | 2016
- A349
-
Comparison of Oral Anti-Coagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation: Two Multi-Criteria Decision AnalysesTervonen, T. / Ustyugova, A. / Lip, G. / Verdecchia, P. / Sri Bhashyam, S. / Heinrich-Nols, J. / Gropper, S. / Kwan, R. / Marsh, K. et al. | 2016
- A350
-
Pay For Performance: A Proposal For And Simulation Of Real Time Outcomes-Based Pharmaceutical Pricing Using Routinely Collected DataButt, T. / Lee, A. / Tufail, A. et al. | 2016
- A350
-
Real-World Impact Of Gender, Age And Socio-Economic Status On Type-2 Diabetes Mellitus (T2dm) Patients’ Disease Engagement And Adherence With Treatment RegimensHiggins, V. / Leith, A. / Benford, M. / Siddall, J. / Piercy, J. et al. | 2016
- A350
-
Differences In Pricing Policies For Generic And Biosimilar MedicinesVogler, S. / P, S. / Gombocz, M. / Zimmermann, N. et al. | 2016
- A350
-
Association Between The Prices Of Orphan Drugs In Oncology And The Patient Population SizesJarosławski, S. / Toumi, M. et al. | 2016
- A350
-
The Determinants Of Innovative Drugs Prices: The Case Of Oncology Drugs, Comparative AnalysisAissaoui, A. / Levy, P. et al. | 2016
- A351
-
ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease PatientsHu, X. / Wood, R. / Jones, E. / Black, C. / Khandker, R. / Ambegaonkar, B. et al. | 2016
- A351
-
Medication Adherence And Persistance In Type 2 Diabetes Mellitus (T2dm): Patients Perspective In Ths Spanish Health Care SystemLabrador Barba, E. / Hernandez Mijares, A. / Alonso Moreno, F. / Rodriguez de Miguel, M. / Orera Peña, M. / Aceituno Mata, S. / Faus Dader, M. et al. | 2016
- A351
-
Advanced Parkinson's Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?Eriksson, JK / Anell, B et al. | 2016
- A351
-
A Framework For Measuring Adherence To Multiple MedicationsPednekar, P. / Agh, T. / Malmenas, M. / Peterson, A. et al. | 2016
- A351
-
Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World DatasetsCuervo, J. / Nordon, C. / Rossignol, M. / Morisot, N. / Benichou, J. / Danchin, N. / Abenhaim, L. / Grimaldi-Bensouda, L. et al. | 2016
- A352
-
The Cost Of Multiple Sclerosis In 16 European Countries: Functional Status, Symptoms And Mental Factors Drive CostsBerg, J. / Gannedahl, M. / Capsa, D. / Eriksson, J. / Thompson, A. / Kobelt, G. et al. | 2016
- A352
-
Excess Costs Associated With Obstructive Sleep Apnea In The ElderlyMenzin, J. / Park, S. et al. | 2016
- A352
-
Heterogeneous Preferences For Delaying Onset Of Alzheimer’s Disease Among Older Adults In The UsReed, S. / Yang, J. / Disantostefano, R. / Streffer, J. / Levitan, B. / Johnson, F. et al. | 2016
- A352
-
Patients' Preferences For Characteristics Of Periodontal Disease And Its' Treatment: A Discrete Choice ExperimentVennedey, V. / Danner, M. / Civello, D. / Schwalm, A. / Seidl, A. et al. | 2016
- A352
-
Nine Tests For Assesing Validity Of A Discrete-Choice ExperimentJanssen, E. / Bridges, J. et al. | 2016
- A353
-
Comparing Preferences Of Patients With Rheumatic Diseases, Of Experienced Rheumatologists, Nurses And Pharmacists Toward The Treatment Of Rheumatic Diseases With Biological Agents: Results From The Cara StudyScalone, L. / Cortesi, P. / Sarzi-Puttini, P. / Sinigaglia, L. / Montecucco, C. / Giacomelli, R. / Lapadula, G. / Olivieri, I. / Giardino, A. / Mecchia, M. et al. | 2016
- A353
-
Defining the Value: Do the New Oncology Frameworks in the Us Aim at Objective Valuation? – A Case Study in Multiple MyelomaForsythe, A / Pezalla, EJ et al. | 2016
- A353
-
Criteria Driving Values Assessments in Multiple Sclerosis MedicinesVisintin, E. / Kanavos, P. et al. | 2016
- A353
-
HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain): Pilot Study Focused in Orphan DrugsGilabert-Perramon, A. / Torrent-Farnell, J. / Catalan, A. / Prat, A. / Fontanet, M. / Puig-Peiró, R. / Merino-Montero, S. / Khoury, H. / Goetghebeur, M. / Badia, X. et al. | 2016
- A353
-
HTA Agencies Perspective on Progression-Free-Survival (PFS)Schmitter, S. / Holzerny, P. / Brock, E. / Günzel, C. / Ruckdäschel, S. et al. | 2016
- A354
-
Economic Evaluation for the United Kingdom of Systemic Chemotherapies as First-Line Treatment for Metastatic Pancreatic CancerGharaibeh, M. / McBride, A. / Alberts, D. / Slack, M. / Erstad, B. / Abraham, I. et al. | 2016
- A354
-
DB1 Mortality Excess Due To Clostridium Difficile Infection - A National Database AnalysisBouee, S. / Levy Bachelot, L. / Ravonimbola, H. / Longepierre, L. / Godard, C. / Gourmelen, J. / Barbut, F. et al. | 2016
- A354
-
Is it Really Cost-Effective to Risk-Assess all Hospitalized Patients for Pressure Ulcers Every Nursing-Shift?Padula, W. / Onyekwere, U. / Makic, M. / Wald, H. / Epstein, Z. / Meltzer, D. et al. | 2016
- A354
-
The Cost-Effectiveness of Bariatric Surgery in Germany, France, Italy and the United KingdomBelarbi, S. / Kusel, J. / Thomas, M. et al. | 2016
- A354
-
Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United KingdomMeng, Y. / Hertel, N. / Ellis, J. / Johnson, H. / Philips, Z. / Roskell, N. / Lee, D. et al. | 2016
- A355
-
Use of Data-Mining to Perform a Real World Cost Analysis of Her2-Positive Breast Cancer In IranAnsaripour, A. / Zendehdel, K. / Tadayon, N. / Sadeghi, F. / Uyl-de Groot, C. / Redekop, W. et al. | 2016
- A355
-
The Relationship Between Medical Innovation And Health ExpendituresCinaroglu, S. / Guzel, E. / Baser, O. et al. | 2016
- A355
-
Economic Burden Of Diseases In France: Analysing The Trends From 2012 To 2014, Using The French Health Insurance Database (Sniiram)Gastaldi Menager, C. / Drouin, J. / Pestel, L. / Fagot-Campagna, A. / Gissot, C. et al. | 2016
- A355
-
A Retrospective Study on Association Between Change In Bmi And Incidence Of Hypertension Using A Health Care Database In JapanYamamoto, Y. / Tanabe, K. / Takahashi, S. / Ii, Y. / Kitazaki, S. / Fujimoto, Y. et al. | 2016
- A355
-
Accuracy Of Natural Language Processing-Based Classifiers For Automated Identification Of Abstracts Of Studies On Humanistic And Economic Burden Of DiseaseKrohn, J. / Martin, A. / Martin, C. et al. | 2016
- A355
-
Modeling The Impact Of Reform To The Cancer Drugs FundKarlsberg Schaffer, S. / Garau, M. / O'Neill, P. / Bianchi, S. et al. | 2016
- A356
-
Decision Uncertainty and Need for Further Research: A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic AneurysmsCiani, O / Epstein, D / Rothery, C / Taylor, RS / Sculpher, M et al. | 2016
- A356
-
Adoption of Transcatheter Mitral Valve Repair in Germany: Utilization Patterns and Case Volumes Compared to Mitral Valve Surgery in the Period 2010-2014Pietzsch, J. / Weber, S. / Pietzsch, M. / Conradi, L. et al. | 2016
- A356
-
MD1 Medical Devices: Timely Access and Reimbursement - Can National Health Technology Assessment Bodies Be Part of the Solution?Macaulay, R. / Shaw, S. et al. | 2016
- A356
-
Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm AnalysisSroczynski, G. / Esteban, E. / Widschwendter, A. / Oberaigner, W. / Borena, W. / von Laer, D. / Hackl, M. / Endel, G. / Siebert, U. et al. | 2016
- A356
-
Comparison Of Time To Reimbursement Decision Of Innovative Pharmaceuticals In EuropeHernandez, J. / Nientker, K. / Hensen, M. et al. | 2016
- A357
-
A Review Evaluating the Validity of Motion-Based Gaming Platforms to Measure Clinical Outcomes in Clinical ResearchByrom, B / Breedon, P / Muehlhausen, W et al. | 2016
- A357
-
Causes of Death Statistics Underestimate the Burden of Head and Neck (H&N) Cancers: A Nationwide Study From France in 2008-2012 (Epicorl Study)Thiébaut, S. / Even, C. / Pointreau, Y. / Geoffrois, L. / Bec, M. / Godard, C. / Levy-Bachelot, L. / Huguet, F. / Témam, S. / Schwarzinger, M. et al. | 2016
- A357
-
Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) and the American Society of Clinical Oncology (Asco) Framework for Assessing Value in Cancer CareRémuzat, C. / Chouaid, C. / Auquier, P. / Kornfeld, A. / Toumi, M. et al. | 2016
- A357
-
Considerations in Meta-Analytic Network Design: The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)Goring, S. / Scott, D. / Briggs, A. / Penrod, J. / Wilson, J. / Waser, N. / Thompson, J. / Korytowsky, B. / Chirita, O. / Wong, B. et al. | 2016
- A358
-
Evaluating the Quality of Evidence From the Aspire and Endeavor Clinical Trials Using the Grading of Recommendations, Assessment, Development and Evaluation (Grade) ApproachBiedermann, P. / Esposito, B. / Glen, C. / Pippo, L. / Avallone, G. / Gonzalez-McQuire, S. / Gatta, F. et al. | 2016
- A358
-
Psychometric Analyses of Clinical Outcome Assessment (Coa) Questionnaires Designed to Evaluate Satisfaction with Pharmacological Stress Agents (Psas) Used in EchocardiographySpalding, J. / Hudgens, S. / Litcher-Kelly, L. / Shields, A. / Kitt, T. / Ojo, O. / Kristy, R. / Lee, E. / Mathias, A. / Morrissey, L. et al. | 2016
- A358
-
Guidelines for Translation and Cross-Cultural Adaptation of Non-Technical Skills Rating InstrumentsRepo, J. / Rosqvist, E. et al. | 2016
- A358
-
Man Versus Machine - Is Accurate Automation of Data Abstraction Achievable?Kiff, C. / Scott, D. / Thompson, J. / Quigley, J. / Eaton, J. et al. | 2016
- A358
-
Single-Arm Trials in Systematic Reviews: Are They Adequately Captured by Existing Search Filters?O'Rourke, J. / Ward, K. / Thompson, J. et al. | 2016
- A358
-
Expected Impact of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) on Health Technology AssessmentRémuzat, C. / Chouaid, C. / Auquier, P. / Borget, I. / Kornfeld, A. / Toumi, M. et al. | 2016
- A359
-
The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool: Which Implications for Value Assessment of Cancer Therapies?Rémuzat, C / Chouaid, C / Auquier, P / Borget, I / Kornfeld, M / Toumi, M et al. | 2016
- A359
-
Patience is a Virtue When Connecting Evidence NetworksHalfpenny, N. / Quigley, J. / Gurung, B. / Scott, D. et al. | 2016
- A359
-
Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)Cork, D. / Nelson, L. / Curry, A. et al. | 2016
- A359
-
Weakness of Registration Bioequivalent DrugsKrakowian, P. / Iwanczuk, T. / Zaremba, A. / Misiak, J. / Tatara, T. / Wysoczanski, W. et al. | 2016
- A359
-
Applying The Accepted Techniques of Indirect Treatment Comparison to Meet Payer Needs For Brivaracetam Versus Adjunctive Antiepileptic Medications for The Treatment of Focal Seizures In Adult Patients. Do they reflect the need for individualised patient care in heterogeneous populations in epilepsy?Charokopou, M. / Harvey, R. / Sristava, K. / Townsend, R. / Borghs, S. et al. | 2016
- A360
-
Optimal Design of Pre-Authorization Trials for Effectiveness Evaluation in Severe AsthmaKarcher, H / Meng, J / Fu, S / Loefroth, E / Cao, H / Peress, E et al. | 2016
- A360
-
Payer Requirements in the Treatment of Chronic Heart FailureBergenheim, K. / Hellsten Kronander, A. / Lauks, S. / van Engen, A. et al. | 2016
- A360
-
A New Model to Identify Multivariate Causes of High Cost in Patient With Advanced Liver DiseaseTurri, J. / Ferreira, L. et al. | 2016
- A360
-
Application of A Value Framework Based on Multiple Criteria Decision Analysis in the Context of Health Technology Assessment: A Series of Case Studies with Decision Makers Across European CountriesAngelis, A. / Kanavos, P. et al. | 2016
- A360
-
Developing A Classification System of Patients Based on Risk Related to Epidemiological and Demographic VariablesRomero Prada, M. / Marrugo, R. / Celis, S. / Alfonso Quiñones, P. / Vivas-Consuelo, D. et al. | 2016
- A361
-
Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes: How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?Elroy, P. / Ronquest, N. / Barnes, A. / Nadipelli, V. / Akehurst, R. et al. | 2016
- A361
-
Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design: An Example in A Rare Cardiac Clinical TrialMarrel, A. / Fofana, F. / Guillemin, I. et al. | 2016
- A361
-
Detection and Analysis of Therapy Lines and Other Event Sequences in Claims DataErtl, J. / Hapfelmeier, J. / Ansorge, S. et al. | 2016
- A361
-
Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis CNagy, L / Kay, G / Parker, C / Padhiar, A / O'Rourke, JM / Quigley, JM / Mealing, S / Hawkins, N et al. | 2016
- A361
-
Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution: A Case Study of Erenumab in Episodic MigrainePorter, J. / Brennan, A. / Palmer, S. / Sapra, S. / Cristino, J. et al. | 2016
- A361
-
Differences in Perception of Health-Related Quality of Life Associates to Socioeconomic, Cultural and Housing Factors: Multilevel AnalysisRomero Prada, M. / Alvis Guzman, N. / Celis, S. / Huerfano, L. / Gallo, D. et al. | 2016
- A362
-
Validating The Projected Mortality Rates Used in Oncology Cost-Effectiveness Analysis: A Pitfall of Simple Benchmarking With Life Table Age-Specific Mortality Rates for A Trial PopulationZhang, Y / Dyer, M / Vereecken, W et al. | 2016
- A362
-
Epidemiological Profile of Knee Arthroplasty Surgery in Health Care System of Public Employees Located in Northeast Brazil Between July 2014 and December 2015Silva, J. / de Souza, N. / Silva, S. / Novis, C. et al. | 2016
- A362
-
Economic and Humanistic Impact Assumptions for Hypoglycemic Events: Implications for Cost-Effectiveness Analyses in Insulin-Treated DiabetesTunis, S. / Klinkenbijl, B. / Graham, C. / Weaver, D. et al. | 2016
- A362
-
Evaluation of the Effect of Pharmaceutical Care Interventions on the Mean Daily Dose of Oral Antidiabetes Drugs in a Nigerian Tertiary HospitalOgbonna, B. et al. | 2016
- A362
-
Four Decades of Rasch Analysis on Patient-Reported Outcomes Instruments Validation: A Systematic Literature Reviewde Bock, E. / Williams, P. / Tugaut, B. et al. | 2016
- A362
-
Review of Methods for Combining Individual and Aggregate Data in a Meta-AnalysisKapso Kapnang, R. / Thokagevistk, K. / Vataire, A. / Aballéa, S. et al. | 2016
- A363
-
Valuing Cancer-Related Premature Mortality: A Comparison of Consumer-Led Versus Producer-Led ApproachesHanly, P. et al. | 2016
- A363
-
Spill Over Economic Impacts on Families of Children Receiving Hospital-Based CareSamnaliev, M. et al. | 2016
- A363
-
Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty: the example of acute myocardial infarctionLomas, J. / Asaria, M. / Bojke, L. / Richardson, G. / Walker, S. et al. | 2016
- A363
-
Health Economic Costing Methods and Reporting in AustriaMayer, S. / Kiss, N. / Laszewska, A. / Simon, J. et al. | 2016
- A363
-
Comparing Different Data on Disease Burden In Multiple SclerosisBerg, J. / Gannedahl, M. / Capsa, D. / Kobelt, G. et al. | 2016
- A364
-
Three Methods for Measuring Productivity Losses Due to Health Related Presenteeism in Economic EvaluationsShephard, C / Hirst, A / Buckland, A / Vlachaki, I / Wang-Silvanto, J et al. | 2016
- A364
-
Valuing Informal Care: Making Normative Judgments in A Positive MilieuHanly, P. / Maguire, R. / Balfe, M. / Sharp, L. et al. | 2016
- A364
-
Systematic Review of Budget Impact Analysis on VaccinesItria, A. / Loze, P. et al. | 2016
- A364
-
A Systematic Literature Review (Slr) of Health-Economic Evaluations of Treatments for Rare DiseasesGarcia Sanchez, J. / Norman, D. et al. | 2016
- A364
-
Evaluating Therapeutic Treatments for Psoriatic Arthritis: Can We Make Better use of Patient Data Registries?Walton, M. / Bojke, L. / Manca, A. / Patton, T. et al. | 2016
- A364
-
Challenges in Economic Evaluations Conducted Alongside Clinical Trials of Schizophrenia: The Case of the Actions StudyKiss, N. / Simon, J. et al. | 2016
- A365
-
The Cost-Effectiveness of Blue-Light Therapy Vs Fixed Combination of Calcipotriol and Betamethasone Dipropionate Gel in the Treatment of Mild-To-Moderate PsoriasisAnsaripour, A / Thio, HB / Maessen, R / Redekop, WK et al. | 2016
- A365
-
Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk: A Discrete Event Simulation ModelCharokopou, M. / Sander, J. / Saha, R. / Beard, S. / Kidd, R. / Coward, E. / Plumb, J. et al. | 2016
- A365
-
A General Model for The Estimation of Societal Costs of Lost Production and Informal Care In ItalyPradelli, L. / Ghetti, G. et al. | 2016
- A365
-
How time and severity increases the overall cost and resource utilization of patient with severe liver disease. Main burdens and consequences to health systemTurri, J. / Ferreira, L. et al. | 2016
- A365
-
The value of timely implementation in hiv/sti testing: cost-effectiveness vs. Speed of intervention rolloutBeck, E. / Armbruster, B. / Birkett, M. / Mustanski, B. et al. | 2016
- A365
-
The Economic Burden of Pulmonary Embolism in EuropeGumbs, P. / Ling-Hsiang Chuang, L. / Cohen, A. / Agnelli, G. / Willich, S. / Monreal, M. / Jimenez, D. / van Hout, B. et al. | 2016
- A366
-
Appropriate Analysis of the Additional Costs of Antibiotic Resistance: The Impact of Different BiasesKaier, K / Heister, T et al. | 2016
- A366
-
Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein OcclusionGoodall, M. / Tosh, J. / Alshreef, A. / Tappenden, P. et al. | 2016
- A366
-
Challenging Model Complexity; A Simpler Approach For Developing MarketsMarijam, A. et al. | 2016
- A366
-
Challenges in the Health Economics of Acute Pain: A Rapid Review of the LiteratureBraileanu, G. / Johnson, B. / Ashraf, S. / Borrill, J. / Hirst, M. et al. | 2016
- A366
-
The Benefits of A Holistic View: Considering Multiple Health Outcomes for Hiv and Sti TestingBeck, E. / Armbruster, B. / Birkett, M. / Mustanski, B. et al. | 2016
- A367
-
Viability Of Using Electronic Medical Records From European Countries As Data In Novelty (A Novel Observational Longitudinal Study Of Patients With Asthma And/Or Copd)Wang, X. / Sveréus, A. / Rennard, S. / Hiller, J. / Wong, D. / Nasuti, P. / Jenner, H. / McKenney, A. / Gerhardsson de Verdier, M. et al. | 2016
- A367
-
Eliciting Payers Preferences In Central And Eastern Europe: Results Of Mcda Case StudyPiniazhko, O. / Zalis'ka, O. / Zah, V. et al. | 2016
- A367
-
Identifying Potential Early Biomarkers Of Acute Myocardial Infarction In The Biomedical Literature: A Comparison Of Text Mining And Manual Sifting TechniquesPaisley, S. / Seva, J. / Stevenson, M. / Archer, R. / Preston, L. / Chilcott, J. / Thornhill, M. et al. | 2016
- A367
-
Linkage Of The Pharmo Database Network And The Netherlands Perinatal Registry To Construct A Cohort That Captures Pregnancy And Postnatal OutcomesHouben, E. / Bezemer, I. / Herings, R. et al. | 2016
- A367
-
Comparison Of Estimated Effectiveness Of Biologics For Rheumatoid Arthritis (Ra) In Large Insurance Databases Using A Claims-Based AlgorithmRascati, KL / Popp, R / Davis, M et al. | 2016
- A367
-
Accuracy Of Text Processing Tokenisers For Automated Identification Of Diseases And Interventions In Abstracts Of Studies On Humanistic And Economic Burden Of DiseaseChallen, R. / Martin, A. / Martin, C. et al. | 2016
- A368
-
Ethical Standards In Reporting Research From Retrospective Observational Studies Based On Databases Using Anonymous And Personally UnidentifiableHiroi, S. / Uda, A. / Tokaji, A. / Takeshima, T. / Iwasaki, K. et al. | 2016
- A368
-
Use Of Surveillance Databases To Describe Influenza Epidemiology In EuropeRiera, M. / Ferreira, G. / Cattaert, T. / Verstraeten, T. et al. | 2016
- A368
-
Artificial Integligence To Support The Development Of Health Technology Assessment ReportsSekiewicz, B. / Rodak, W. / Rutkowski, J. / Plisko, R. / Miazga, P. et al. | 2016
- A368
-
The Use Of Administrative Data To Determine Prevalence And Incidence Of Copd: A Systematic ReviewGothe, H / Rajsic, S / Gottfried, E / Vukicevic, D / Siebert, U et al. | 2016
- A368
-
Pediatric Registry Of Patients With Severe Persistent Uncontrolled Asthma Receiving OmalizumabNamazova-Baranova, L. / Vishneva, E. / Dobrynina, E. / Alekseeva, A. / Levina, J. / Efendieva, K. / Smirnov, V. / Antonova, E. / Voznesenskaya, N. / Selimzianova, L. et al. | 2016
- A369
-
Measures Taken By The Romanian Ministry Of Health For Better Access To Anti-Egfr DrugsTurcu-Stiolica, A. / Subtirelu, M. / Mic, O. et al. | 2016
- A369
-
Prediction Of Costs Associated With The Hospital Management Of Hiv Patients In France Using An Advanced Data Mining Approach On The French Medical Information System DatabaseProdel, M. / Amaz, C. / Vainchtock, A. / Finkielsztejn, L. / Aubin, C. et al. | 2016
- A369
-
Development Of A Search Engine For The Medline Database With Search Results Ranking From The Perspective Of Evidence-Based MedicineKolbin, A. / Kamalov, M. / Dobrynin, V. / Balykina, Y. / Verbitskaya, E. et al. | 2016
- A369
-
Proqolid Database: Evolution Of Content, Structure, And Functionalities (2012-2016) - Integration In Eprovide, A New Online Platform Dedicated To Clinical Outcome Assessment (Coa) ResearchPerret, C. / Perrier, L. / Castex, M. / Acquadro, C. et al. | 2016
- A369
-
Markov Models For Health Economic Evaluation Modelling In R With The Heemod PackageFilipovic-Pierucci, A. / Zarca, K. / Durand-Zaleski, I. et al. | 2016
- A369
-
An Investigation Into Open-Source Modelling In Health Economics: Opportunities And ChallengesMason, N. / Kenworthy, J. / Akehurst, R. / Sullivan, W. / Dunlop, W. et al. | 2016
- A370
-
Characteristics Of A Patient Population Recruited Using Social Media (Facebook) Compared With Newspaper Advertising (Daily Mail)Wade, AG / Crawford, GM / McLennan, K et al. | 2016
- A370
-
Network Analysis Approach To Explore Sponsor Involvement In Clinical TrialsMerész, G. / Kozák, A. / Hankó, B. / Szócska, M. et al. | 2016
- A370
-
Expert Elicitation: Can Variation In Elicited Distributions Be Explained By Expert Heterogeneity?Jankovic, D. et al. | 2016
- A370
-
Evaluating Socio-Demographic Characteristics Of Patients In The United States Department Of Defense PopulationWang, L. / Li, L. / Pandya, S. / Baser, O. et al. | 2016
- A370
-
Mapping The Involvement Of Eunethta Participants In Eu Research ProjectsKozák, A. / Hankó, B. / Lám, J. / Merész, G. et al. | 2016
- A371
-
Quinolones Utilization In Two Tertiary Hospitals In Nigeria; Exploring Drug Use Towards Improved Treatment OutcomesOgbonna, B. et al. | 2016
- A371
-
A Systematic Review on the Evidence of Adequate Discount Rates for Vaccines in GermanyKoerber, F / Redeker, M / Wieninger, E / Welte, R et al. | 2016
- A371
-
Not All Cochrane Reviews Are Good Quality Systematic ReviewsDeshpande, S. / Misso, K. / Westwood, M. / Stirk, L. / de Kock, S. / Kleijnen, J. / Clayton, D. et al. | 2016
- A371
-
Missing the Value of Herd Immunity in Cost-Effectiveness Analysis. A Systematic ReviewNymark, L. et al. | 2016
- A371
-
Analysis of the Relationship Between Blood Pressure in Health Checkup and Effectiveness of AntihypertensivesKoizumi, H. / Nakamura, Y. / Iwasaki, K. / Hiroi, S. / Uda, A. / Shimasaki, Y. et al. | 2016
- A371
-
Implications of Introducing Patient Heterogeneity in Cost Effectiveness ModelingFoos, V. / McEwan, P. / Lamotte, M. et al. | 2016
- A372
-
The Implications of Parameter Independence in Probabilistic Sensitivity AnalysisTaylor, M. et al. | 2016
- A372
-
Replacing Input Probability Distributions with Mean Values can Bias Simulation Output: An Illustration Using the Core Diabetes ModelMcEwan, P. / Foos, V. / Lamotte, M. et al. | 2016
- A372
-
Comparison of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic ReviewSilva, N. et al. | 2016
- A372
-
Structured Review of Health Economic Models in AsthmaEnstone, A. / Price, G. / Viejo, I. / Dunlop, W. et al. | 2016
- A372
-
Empirical Assessment of the Impact of Model Choice (Markov State Transition Versus Partitioned Survival) in Modelling Small-Cell Lung CancerMcEwan, P. / Gordon, J. / Ward, T. / Penrod, J. / Yuan, Y. et al. | 2016
- A373
-
Potential Efficacy of Lomitapide, A MTP (Microsomal Triglyceride Transfer Protein) Inhibitor, on Survival in Homozygous Familial Hypercholesterolaemia (HOFH): Results of an Event Modelling AnalysisLeipold, R / Raal, F / Ishak, J / Phillips, H / Deanfield, J et al. | 2016
- A373
-
Recommendations for the Calculation of Transition Probabilities in Markov Cohort Models: A Targeted Literature ReviewOlariu, E. / Cadwell, K. / Fox, D. / Hancock, E. / Trueman, D. / Ratcliffe, M. / Grieve, R. / Chevrou-Severac, H. et al. | 2016
- A373
-
Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language ProcessingCaccamisi, A. / Jörgensen, L. / Dalianis, H. / Rosenlund, M. et al. | 2016
- A373
-
Review of Health Economic Models for AntibioticsVirhage, M. / Polyzoi, M. / Geale, K. / Corcoran, K. / Anell, B. et al. | 2016
- A373
-
To What Extent Does the Published Economic Analyses of Treatments for Opioid Use Disorder Capture its Chronic, Relapsing Nature and its Impact on Society?Cranmer, H. / Ronquest, N. / Barnes, A. / Nadipelli, V. / Akehurst, R. et al. | 2016
- A373
-
Modelling the Cost-Effectiveness of Treatment Strategies in Chronic Lymphocytic Leukaemia, Follicular Lymphoma and Multiple Myeloma: A Review and Critical Appraisal of the Published LiteratureKankeu, T. H. / Manca, A. et al. | 2016
- A374
-
Extrapolation with Patient Level Time-To-Event Data in Various Disease Areas: A Review of Current Recommendations and GapsKamra, S. / Kaur, J. / Kartheek, J. / Sehgal, M. / Siddiqui, M. et al. | 2016
- A374
-
Accounting for the Imperfect External Validity of Discrete Choice Experiments When Predicting DemandQuaife, M. / Terris-Prestholt, F. / Di Tanna, G. / Vickerman, P. et al. | 2016
- A374
-
The Impact of the Difference in Natural History Models on the Cost-Effectiveness of Antiviral Agents for Patients with Genotype 1 Chronic Hepatitis CIshida, H. / Ikai, H. / Suenaga, R. / Suka, M. / Hirao, T. et al. | 2016
- A374
-
Deterministic Vs Microsimulation; A Case Study In Systemic Lupus Erythematosus (SLE)van Oostrum, I. / Guenther, O. / Postma, M. / Heeg, B. et al. | 2016
- A374
-
Use of the Pert and Uniform Distributions with the Central Limit Theorem (CLT) to Decrease Variance in Complication Cost Estimation in Probabilistic ModelsReynecke, D. / Robson, J. et al. | 2016
- A375
-
Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) ModelNemeth, B / Kulchaitanaroaj, P / Lester-George, A / Huic, M / Pokhrel, S / Coyle, D / Coyle, K / Kaló, Z / Józwiak-Hagymásy, J et al. | 2016
- A375
-
Systematic Review of Cost-Effectiveness Models in Diabetes for Insulin AnaloguesNg, C. / Shafie, A. / Chaiyakunapruk, N. / Tan, Y. et al. | 2016
- A375
-
Cost-Effectiveness Depends on the Subsequent Treatment Sequence: An Example from Multiple SclerosisAsseburg, C. / Svensson, J. / Andersson, E. / Persson, U. / Willis, M. et al. | 2016
- A375
-
Sampling of Commonly used Population Characteristics: Is A Normal Approximation Valid?Davis, J. / Mittard, V. / Saunders, R. et al. | 2016
- A375
-
Evaluation of Methodological Variations in the Event Simulation Approaches of Published Health Economic Models in Obesity Prevention and TherapySchwander, B. / Nuijten, M. / Hiligsmann, M. / Evers, S. et al. | 2016
- A376
-
Multithreading: Turbocharged Cost-Effectiveness Analyses in Microsoft ExcelKiff, C. / Mealing, S. / Fenwick, E. et al. | 2016
- A376
-
A Novel Method for Evaluating Value Assessment FrameworksBentley, T. / Cohen, J. / Elkin, E. / Huynh, J. / Mukherjea, A. / Neville, T. / Mei, M. / Copher, R. / Knoth, R. / Popescu, I. et al. | 2016
- A376
-
How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HASPibouleau, L. / Drezet, A. / Cognet, M. / Scemama, O. / Le galès, C. et al. | 2016
- A376
-
Treatment Efficacy in Sequence Modelling – A Review of Published ApproachesPolyzoi, M / Medin, E et al. | 2016
- A376
-
Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal CancerMerkens, G. / Tamminga, H. / Hovels, A. / Frederix, G. et al. | 2016
- A376
-
How to Handle Data Quality Issues in EQ-5D-5L Valuation Studies. The Spanish CaseRamos-Goñi, J. / Craig, B. / Oppe, M. / Ramallo-Fariña, Y. / Pinto-Prades, J. / Luo, N. / Rivero-Arias, O. et al. | 2016
- A377
-
Requirements for Economic Evidence Across Different HTA BodiesVlachaki, I. / Wang-Silvanto, J. / Shephard, C. / Hirst, A. et al. | 2016
- A377
-
The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic ReviewJahn, B. / Conrads-Frank, A. / Sroczynski, G. / Rochau, U. / Zauner, G. / Bundo, M. / Gyimesi, M. / Endel, G. / Popper, N. / Siebert, U. et al. | 2016
- A377
-
Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/DementiaGustavsson, A. / Green, C. / Jones, R. / Simsek, D. / de Reydet de Vulpillieres, F. / Adlard, N. / Bhattacharyya, S. / Wimo, A. / Förstl, H. / Luthman, S. et al. | 2016
- A377
-
Hyperbolic Discounting of Effects in Economic EvaluationsFókás, L. et al. | 2016
- A377
-
A Review on the Current Status of Health Economic Modeling in Personalized MedicineDegeling, K. / Koffijberg, H. / IJzerman, M. et al. | 2016
- A378
-
Mathematical Model to Synthesize Natural History of Tick Borne Encephalitis and Lyme Borreliosis for the Purpose of Cost-Effectiveness AnalysisMihajlovic, J. / Hovius, J. / Sprong, H. / Strle, F. / Bogovic, P. / Postma, M. et al. | 2016
- A378
-
Adaptive Prediction of Symptoms Return Upon Discontinuation of Omalizumab Treatment in Chronic Spontaneous Urticaria PatientsSaldana Miranda, D. / Ferrer, M. / Janssens, N. / Gimenez-Arnau, A. / Balp, M. / Khalil, S. / Risson, V. et al. | 2016
- A378
-
Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in FranceArteaga Duarte, C. / Colin, X. / De Moor, R. / Guillon, P. / van Gils, C. et al. | 2016
- A378
-
An Exploration of Techniques for Addressing Uncertainty in Survival Estimates used Within Partitioned-Survival ModelsBullement, A. / Critchlow, S. et al. | 2016
- A378
-
Estimating the Appropriate Price Discounts for Biosimilars in the Treatment of Rheumatoid Arthritis in the Nordic Setting Using an Excel-Based Interactive ToolMahon, R. / Cassel, T. / Balkin, P. / Burke, C. / Bhattacharyya, S. / Gokhale, S. / Handin, J. / Mendoza, C. et al. | 2016
- A379
-
Investigating the Implementation of Adverse Events in Economic Models: A Systematic Literature Review in Multiple Sclerosis and Human Immunodeficiency VirusGillies, H. / Polyzoi, M. / Medin, E. et al. | 2016
- A379
-
The Importance of Model Conceptualisation: A Case Study in Ankylosing Spondylitis (AS) and Non-Radiographic Axial Spondyloarthritis (NR-AXSPA)Sideris, E. / Soares, M. / Palmer, S. et al. | 2016
- A379
-
Understanding the Policy-Relevant Portion of the Efficient Frontier in Screening Interventions: The Importance of Comparator StrategiesO'Mahony, J. et al. | 2016
- A379
-
Influence of Air Pollution on Some Pregnancy Outcomes and Burden of Pneumonia on Children Under Five Years Old in MongoliaDorj, G / Gendenragchaa, B / Sanjjav, T et al. | 2016
- A379
-
Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)Bjorner, J. / Rendas-Baum, R. / Carson, R. / Boer, R. / Tucker, C. / Andrae, D. / Brazier, J. et al. | 2016
- A379
-
Do Health Technology Agencies Accept Methods for Dealing with Treatment Switching and Immature OS Data?Zhang, Y. / Wright, J. / Luke, S. / Ryan, J. / van Engen, A. et al. | 2016
- A380
-
Defining Real-World Product Performance Using Survival Analysis and Superivsed Machine LearningGeldof, T. / van Dyck, W. / Moreau, Y. et al. | 2016
- A380
-
Comparison Study Based on Simulation of Patient Pathways Using Multi-State Models in OncologyRakonczai, P. / Lang, Z. / Balazs, T. / Bacskai, M. et al. | 2016
- A380
-
Comparative Efficacy of Time to Virologic Suppression in Treatment-Naive HIV-1 Patients: A Network Meta-Analysis of Longitudinal DataSnedecor, SJ et al. | 2016
- A380
-
Investigating the Effects of Testing and Adjusting for Nonlinearity using Categorization in Prediction Models with Costs as OutcomeBrouwers, D. / Nieboer, D. / Bosmans, J. / van Tulder, M. / Heymans, M. / van Dongen, J. et al. | 2016
- A380
-
Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents: An Exploratory Evaluation using Advanced Hierarchical Network Meta-Analysis TechniquesLangford, B. / Wickstead, R. / Marsh, W. / Beale, R. / Evans, J. / Kusel, J. / Griffiths, M. et al. | 2016
- A381
-
Statistical Models to Predict Indication of Respiratory Patients Between Asthma and COPDIlgin, Y. / Staus, A. / Chauvin, F. / Leheyda, N. / Wolk, A. / Witte, M. / Subramani, S. et al. | 2016
- A381
-
Brain Metastasis Prediction in Breast Cancer Women: Usefulness of Mathematical Modeling of MontecarloSat-Muñoz, D / Balderas-Peña, L / Cruz-Corona, E / Ortiz-González, F / Chagollán-Ramírez, J / Chávez-Hurtado, J et al. | 2016
- A381
-
Methodological Review of Survival Models: Application to A Persistence Analysis Based on Long Acting Parenteral Antipsychotic in Retail Pharmacies in FranceHarmand, S. / El Mouaddin, N. et al. | 2016
- A381
-
Predicting Patient-Reported Outcomes from Disease-Specific Questionnaires: A Comparison of Seven MethodologiesGheorghe, M. et al. | 2016
- A381
-
Generalising Results from Cost-Effectiveness Analysis: A Comparison of Methods to Account for CovariatesMantopoulos, T. / Dias, S. / Welton, N. et al. | 2016
- A382
-
Reflecting Uncertainty in Early HTA When Evidence on Parameter Distributions is Lacking: A Comparison of MethodsKoffijberg, H. / Degeling, K. / Janssen, M. / IJzerman, M. et al. | 2016
- A382
-
Developing A Conceptual Framework and a Tool for Measuring Absorptive Capacity in Pharmaceutical CompaniesSanati, E / Kebriaeezadeh, A / Davari, M / Abdollahi asl, A / Keshavarz, K et al. | 2016
- A382
-
Correctly Capturing Uncertainty in Treatment Effects in Simulation ModelingWillis, M. / Asseburg, C. et al. | 2016
- A382
-
Boosting a Modeller's Armoury: Pursuing Realistic and Efficient Competing Risk Health Economic Models (HEMS)Kay, S. et al. | 2016
- A382
-
Lenalidomide for Treating Multiple Myeloma After 1 Prior Treatment; An Application of Multi-State Markov Modelling for the Extrapolation of Patient Level Survival DataSaunders, O. / Gregory, J. / Lee, D. / Farrell, J. et al. | 2016
- A382
-
Methods for Time-Varying Exposure – A Literature ReviewLinder, M. / Vago, E. / Bahmanyar, S. / Heeg, B. / Myers, D. / Zhang, M. / Andersen, M. et al. | 2016
- A383
-
Quality of Life of Patients Treated for Multiple Myeloma (MM) in France in a Real-World SettingDespiegel, N. / Touboul, C. / Flinois, A. / Saba, G. / Gonzalez-McQuire, S. / Suzan, F. / Blachier-Poisson, C. / Guilhaume, C. et al. | 2016
- A383
-
Further Validation of the Haemopref in a Real-World SettingTolley, C. / Staunton, H. / Brohan, E. / Spurden, D. / Cicchetti, M. / Cappelleri, J. et al. | 2016
- A383
-
Key Aspects in the Modelling of Dengue Transmission: Results from a Focused Literature ReviewKharitonova, E. / Aballea, S. / Knerer, G. et al. | 2016
- A383
-
Using Acoustic Simulations of Hearing Loss to Describe Health States: Are they Feasible and Reliable to use?Williams, N. / Pierzycki, R. / Akeroyd, M. / Kitterick, P. et al. | 2016
- A383
-
Development of a Responder Definition for the Migraine Physical Function Impact Diary (MPFID)Kawata, A. / Hsieh, R. / Sapra, S. / Desai, P. / Ortmeier, B. / Poon, J. / Tepper, S. / Stewart, W. / Dodick, D. / Hareendran, A. et al. | 2016
- A384
-
A New Approach to Presenting Health States in Stated Preference Valuation StudiesCole, AM / Shah, K / Mulhern, B / Feng, Y / Devlin, N et al. | 2016
- A384
-
Measuring Caregiver Quality of Life; Which Aspects Really Matter?Efthymiadou, O. et al. | 2016
- A384
-
Valuation of EQ-5D-5L Health States: A Comparison of Three Asian CountriesLuo, N. / Wang, P. / Liu, G. / Juntana, P. et al. | 2016
- A384
-
An International Patient Survey on Health Related Quality of Life Aspects not Cpatured by EQ-5D-5LMossman, J. / Efthymiadou, O. / Kanavos, P. et al. | 2016
- A384
-
External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous MelanomaFranken, M. / Leeneman, B. / Jochems, A. / Schouwenburg, M. / Aarts, M. / van Akkooi, A. / van den Berkmortel, F. / van den Eertwegh, A. / Groenewegen, G. / de Groot, J. et al. | 2016
- A385
-
To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision AnalysisGoetghebeur, MM / Samaha, D / Khoury, H / O'Neil, B / Lavoie, L / Bennetts, L / Wagner, M / Badgley, D / Gabriel, S / Berthon, A et al. | 2016
- A385
-
The Quality-Adjusted Time Without Symptoms and Toxicity (Q-TWIST) in (IMMUNO)-Oncology: A Systematic Review of the LiteratureWan, Y. / Tai, M. / Botteman, M. et al. | 2016
- A385
-
An Anchor-Based Approach to Define an Impaired Day in Migraine Patients Utilizing the Migraine Physical Function Impact DiaryKawata, A. / Hsieh, R. / Sapra, S. / Desai, P. / Ortmeier, B. / Gleeson, S. / Revicki, D. / Lipton, R. / Bayliss, M. / Hareendran, A. et al. | 2016
- A385
-
Psychometric Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) QuestionnaireGomberg-Maitland, M. / Channick, R. / Chin, K. / Fischer, A. / Frantz, R. / Roberts, L. / Miller, C. / Hunsche, E. / Zamanian, R. / Zastrow, M. et al. | 2016
- A385
-
Development of a Mapping Algorithm Between the SGRQ and EQ-5D-5L Utility Values in a Severe Asthma PopulationWillson, J. / Mukuria, C. / Labeit, A. / Gunsoy, N. / Starkie Camejo, H. / Alfonso-Cristancho, R. / Brazier, J. et al. | 2016
- A386
-
The Impact of Country-Specific Utility Tariffs on the Outcome of Cost-Utility Analyses; A Case StudyBosmans, J. / Rossenaar, M. / van Dongen, J. / van Tulder, M. et al. | 2016
- A386
-
Conceptual Model and Clinical Outcomes Assessments for Angelman’s Syndrome: Utilizing Pragmatic Methods in Rare DiseasesAbetz-Webb, L. / Cabo, R. / Grieco, J. / Rakhit, A. / During, M. et al. | 2016
- A386
-
Eliciting Stated Preferences Regarding Life Extensions Near the End of Life: A Pilot Study for a Refinement of the QalyTaylor, M. / Filby, A. / Elvidge, J. et al. | 2016
- A386
-
Using Orthogonal Design in Selecting Health States for the Construction of EQ-5D-3L Value SetYang, Z. / Luo, N. / van Busschbach, J. / Stolk, E. et al. | 2016
- A386
-
Analyzing a German Index for the EQ-5D-5L Based on Experienced HealthLeidl, R. / Reitmeir, P. et al. | 2016
- A386
-
Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF)Evans, E. / Taylor, F. / Patki, A. / Ojo, O. / Lamoureux, R. / Horny, H. / Reiter, A. / Gotlib, J. / Shields, A. et al. | 2016
- A387
-
What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision AnalysisGoetghebeur, M. / Samaha, D. / O'Neil, B. / Khoury, H. / Bennetts, L. / Lavoie, L. / Wagner, M. / Badgley, D. / Gabriel, S. / Berthon, A. et al. | 2016
- A387
-
"Why Can't I Just Use Google Translate?" A Study on the Effectiveness of Online Translation Tools in Translation of CoasLear, A. / Oke, L. / Forsythe, C. / Richards, A. et al. | 2016
- A387
-
A Systematic Review of Utility Derivation Methods: Time Trade off in Comparison to EQ-5DVollmer, L / Shannon, RJ / Walzer, S et al. | 2016
- A387
-
Health-Related Quality of Life in Opioid use Disorder Measured by Utilities: A Systematic Literature ReviewCranmer, H. / Ronquest, N. / Barnes, A. / Nadipelli, V. / Akehurst, R. et al. | 2016
- A387
-
Reconsidering EQ-5D; Quality of Life Domains that are Important for Multiple Sclerosis PatientsMossman, J. / Efthymiadou, O. / Tinelli, M. / Kanavos, P. et al. | 2016
- A388
-
Content Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) QuestionnaireGomberg-Maitland, M. / Channick, R. / Chin, K. / Fischer, A. / Frantz, R. / Roberts, L. / Miller, C. / Hunsche, E. / Zamanian, R. / Badesch, D. et al. | 2016
- A388
-
Fore! Sweeping Generalisations do not Bowl Over all Cultures… Cultural Adaptation in the Kidney Disease Quality of Life QuestionnaireRichards, A. / Mead, H. / Towns, L. et al. | 2016
- A388
-
A Study of the Successful Adaptation of the Quality of Life Questionnaire - Bronchiectasis From Paper To Electronic FormatSimpson, H. / Ong, S. / Quittner, A. / McEvoy, K. / Dhariwal, M. et al. | 2016
- A388
-
Systematic Review of Psychometric Properties of The EQ-5D Questionnaires In Patients with Hematologic Malignant NeoplasmsMlynczak, K. / Wojcik, A. / Golicki, D. et al. | 2016
- A388
-
Qualitative Research Approaches In Rare Diseases: Acid Sphingomyelinase Deficiency (ASMD) Symptoms and Impact as Reported by Patients and CaregiversAvetisyan, R. / Hareendran, A. / Stringer, S. / Tan, S. / Sanson, B. / Hass, S. et al. | 2016
- A389
-
Understanding the Utility Value of Patients with Heavily Pre-Treated Multiple MyelomaHadi, M. / Swinburn, P. / de Freitas, H. / Ito, T. et al. | 2016
- A389
-
Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study ResultsGerlinger, C. / Bamber, L. / Leverkus, F. / Schwenke, C. / Haberland, C. / Schmidt, G. / Endrikat, J. et al. | 2016
- A389
-
Well-Being: What Is It, How Does it Compare to Health and What are the Implications of Using it to Inform Health Policy?Brazier, J. / Mukuria, C. / Peasgood, T. / Bjorner, J. et al. | 2016
- A389
-
Cross-Cultural Adaptation of the Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD) and the Caregiver Global Impression Scales in 13 LanguagesLe Scouiller, S. / Edgar, C. / Rylands, A. / Giroudet, C. / Regnault, A. / Zarit, S. / Rofail, D. et al. | 2016
- A389
-
Using Analytic Hierarchy Process to Weight Patient-Relevant Outcomes in the Treatment of Psoriasis for Calculating the Patient Benefit IndexGutknecht, M. / Danner, M. / Augustin, M. et al. | 2016
- A389
-
Translatability Evaluation of the Rome IV Diagnostic Questionnaire for AdultsCrane, A. / Popielnicki, A. / Sperber, A. / Drossman, D. / Palsson, O. / Whitehead, W. / Sweeney, E. / O'Brien, K. et al. | 2016
- A390
-
Translation of Chinese Version of Measure Yourself Medical Outcome Profile (MYMOP) And Application In The Coronary Heart DiseaseZhang, F. / Zhang, S. / Wang, Y. / Zhang, Z. / Yang, G. et al. | 2016
- A390
-
Translation of the DN4 (Douleur Neuropathique EN 4 Questions) INTO 85 Languages: Challenges and Importance of the Conceptual Defintion of the Original VersionBouhassira, D. / Dulac, M. / Bindi, P. / Nguyen, A. / Acquadro, C. et al. | 2016
- A390
-
Multiple Myeloma and Health-Related Quality of Life from EQ-5D and EORTC: A Systematic Literature ReviewJahn, B. / Vukicevic, D. / Jevdjevic, M. / Holzner, B. / Kemmler, G. / Siebert, U. / Rochau, U. et al. | 2016
- A390
-
Performance of Search Filters to Identify Health State Utility StudiesArber, M / Garcia, S / Veale, T / Edwards, M / Shaw, A / Glanville, J et al. | 2016
- A390
-
Euroqol To Assess The Quality of Life with SmartphoneVorobiev, A. / Vorobiev, P. / Krasnova, L. / Vorobiev, M. et al. | 2016
- A391
-
Viewpoints of Thalassaemia Patients on the Combination of Traditional & Complementary Medicine (T&CM) with the Conventional Thalassaemia Treatment:A Qualitative Understanding ApproachIsmail, w. / Hassali, M. / Farooqui, M. / Saleem, F. et al. | 2016
- A391
-
Recommendations on Cognitive Debrief and Usability Studies for Instrument Migration from Paper to Electronic Modalities Based on A Qualitative Synthesis of Validation StudiesMuehlhausen, W. / Byrom, B. / Skerritt, B. et al. | 2016
- A391
-
Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic ApplicationsKulis, D. / Bottomley, A. / Holzner, B. / Koller, M. / Swinburn, P. / Itani, A. et al. | 2016
- A391
-
Linguistic Validation and Electronic Migration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)Sydor, B. / Spertus, J. et al. | 2016
- A391
-
Linguistic Validation of the Injection-Treatment Acceptance Questionnaire (I-TAQ)Crane, A. / Popielnicki, A. / Sanchez, R. et al. | 2016
- A391
-
When Should Translations of Clinical Outcome Assessments (COAS) be Considered Obsolete? Recommendations from MAPI’S Translations Life Expectancy Working GroupGiroudet, C. / Salmassi, L. / Prill, M. / Berne, C. / Berrou, M. / Boudrot, A. et al. | 2016
- A392
-
Comparison of Methods for Indirect Treatment Comparison Combining Individual and Aggregate Patient Data: A SimulationRasouliyan, L. et al. | 2016
- A392
-
An a Priori Decision Criteria Elicitation Method for Treatment Decision-Making in Elderly Colorectal Cancer PatientsKeizer, J. / IJzerman, M. / van Til, J. / Wymenga, A. et al. | 2016
- A392
-
Incorporating Biometric Data from Wearable Activity Trackers with Study Data in France and the UKFink, L. / Chanot, G. / Bernard, F. / Mondry, B. / Bondarenko, K. et al. | 2016
- A392
-
Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to Benefit (PTB) and Reveal Unmet Medical Need (UMN)Soini, E. / Heinonen, J. / Miettola, E. / Ryynänen, O. / Koskela, T. et al. | 2016
- A392
-
The Economic Impact of Influenza-Like Illness on Families Living in the UK Demonstrated by the Collection of Online DataWade, A. / Crawford, G. / McLennan, K. et al. | 2016
- A393
-
The Added Value of Real-World Evidence to Connect Disconnected Networks for Network Meta-Analysis: A Case Study in Rheumatoid ArthritisJenkins, D. / Martina, R. / Dequen, P. / Bujkiewicz, S. / Abrams, K. et al. | 2016
- A393
-
Identifying Higher-Value Subpopulations For Treatment In Heterogenous Rare Diseases: An Example Study of Early Responders to Teduglutide for Short Bowel SyndromeChen, K. / Xie, J. / Tang, C. / Zhao, J. / Olivier, C. / Jeppesen, P. / Signorovitch, J. et al. | 2016
- A393
-
Comparison of Bayesian Network Meta-Analyses in a Winbugs and SAS FrameworkLe Moine, J. / Abeysinghe, S. et al. | 2016
- A393
-
Adjusting Variance Parameters to Incorporate Uncertainty into Health Economics Models Following Treatment SwitchingRay, J. / Bennett, I. / Paracha, N. et al. | 2016
- A393
-
Extracting Dosage Per Day From Free-Text Medication PrescriptionsTörnblom, M. / Bergman, G. / Jørgensen, L. / Fackle-Fornius, E. / Rosenlund, M. et al. | 2016
- A394
-
Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors Among Undergraduate Male Students In An Ethiopian University: A Cross-Sectional StudyGebreyohannes, E. / Bhagavathula, A. / Tefera, Y. / Belachew, S. et al. | 2016
- A394
-
A Systematic Literature Review on the Efficacy-Effectiveness Gap: Comparison of Randomized Controlled Trials and Observational Studies of Glucose-Lowering DrugsAnkarfeldt, MZ / Adalsteinsson, E / Groenwold, RH / Ali, S / Klungel, O et al. | 2016
- A394
-
Is Early Initiation of Biologic Treatment more Effective than a Step up Treatment Approach for New Onset Juvenile Idiopathic Arthritis?-- using a Causal Inference Approach to Achieve a Double Robust EstimateHuang, B. / Morgan, E. / Chen, C. / Adams, M. / Sivaganisan, S. / Brunner, H. / Guo, J. / Seid, M. et al. | 2016
- A394
-
The Use of ‘Off The Shelf’ Informative Prior Distributions In Random Effect Network Meta-Analysis ModelsBatson, S. / Abrams, K. / Sutton, A. et al. | 2016
- A394
-
Network Meta-Analysis Across Longitudinal Time Points: A Comparison of Available MethodsTallarita, M. / de Iorio, M. / Baio, G. / Karabis, A. et al. | 2016
- A394
-
Adjustment Of OS In Crystal For Post-Study Anti-Cancer TherapiesStapelkamp, C. / Byrne, B. / van Hout, B. et al. | 2016
- A395
-
Important Methodological Considerations and Strategies for Resolution for Multinational Retrospective Chart Review StudiesBassel, M. et al. | 2016
- A395
-
Making Sense of Clinical Data Reported in Secondary Conditions: The Epidemiology and Clinical Burden of HyperglycaemiaCadwell, K. / Pooley, N. / Olariu, E. / Jones, G. / Papageorgakopoulou, C. / Fox, D. et al. | 2016
- A395
-
How to Maximise the Value and Payers’ Acceptance of Single Arm Trial Data in Oncology?Hoyle, C. / Wright, J. / Ede, J. / van Engen, A. / Ryan, J. et al. | 2016
- A395
-
Adapting to the Challenge: How are Innovative Study Designs Being used in Rare Diseases?Berry, L. / Eddowes, L. et al. | 2016
- A395
-
Validity and Reliability of Three New Instruments for Parents and Children Assessing Nutrition and Physical Activity Behaviors, Environment and Knowledge and Health in Childhood and Adolescence in Greece During the Economic Recession: Data from the National Action Plan for Public Health (MIS301205)Carayanni, V. / Vlachopapadopoulou, E. / Psaltopoulou, T. / Koutsouki, D. / Bogdanis, G. / Karachaliou, F. / Manios, Y. / Kapsali, A. / Papadopoulou, A. / Hatzakis, A. et al. | 2016
- A396
-
Generating Real World Evidence: Guidance On The Design And Conduct Of Retrospective Chart Review StudiesKorol, E. / Osenenko, K. / Kayaniyil, S. / McMullen, S. et al. | 2016
- A396
-
Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In EuropeGerlier, L. / Sidelnikov, E. / Kutikova, L. / Lamotte, M. / Annemans, L. et al. | 2016
- A396
-
Quasi-Experimental Methods For Real World DataMenke, J. et al. | 2016
- A396
-
When Is The Use Of A Systematic Literature Review Appropriate? A Comparison Of Systematic, Rapid, And Scoping Reviews And Their Application To The Hta ProcessPooley, N. / Olariu, E. / Floyd, D. et al. | 2016
- A396
-
Making Pragmatic Trials WorkZuidgeest, M. / Stolk, P. / Oude Rengerink, K. / Goetz, I. / Welsing, P. / Grobbee, D. et al. | 2016
- A396
-
The Case For Bayesian Methods In Benefit-Risk Assessment: Overview And Future DirectionsJemiai, Y. / Costa, M. / DiCasoli, C. / Pap, A. / He, W. / Zhao, Y. / Crane, M. et al. | 2016
- A397
-
Multi-Criteria Decision Analysis From The Cost-Effectiveness Perspective: Is Mcda A Coherent Way To Allocate Healthcare Resources?O'Mahony, JF et al. | 2016
- A397
-
Health Economics Analysis Plans: Where Are We Now?Thorn, J. / Ridyard, C. / Hughes, D. / Wordsworth, S. / Mihaylova, B. / Noble, S. / Hollingworth, W. et al. | 2016
- A397
-
Application Of Quality Indicators To Enable Economic Evaluation Of Quality Improvements – A Bayesian Decision Theoretical And Value Of Information Analytical FrameworkVestergaard, A. / Holger Ehlers, L. et al. | 2016
- A397
-
Innovative Approach To Keeping Evidence Current And Guidelines LivingLewis, S. / Newton, M. et al. | 2016
- A397
-
Comparison Between Cancer Drugs Assessment In Portugal And United KingdomCarmo, S. / Ramos, R. / Crespo, N. et al. | 2016
- A397
-
Methods For The Design And Conduct Of Medical Record Reviews In OncologyWilke, T. / Baeten, S. / Solem, C. / Penrod, J. / Verleger, K. / Lees, M. / Manley Daumont, M. et al. | 2016
- A398
-
Guidance On Selecting Appropriate Methods When Considering Adjusting Overall Survival For Treatment Switch In Oncology StudiesWatkins, C. / Latimer, N. / Wang, J. / Wright, E. et al. | 2016
- A398
-
Interactive Health Economic Models Configured With Google Analytics. Data And Metrics Applicable For A Healthcare ResearchTopachevskyi, O. / Siabro, V. / Volovyk, A. et al. | 2016
- A398
-
Using Evidence Reviews To Develop Focused Systematic Review QuestionsUpton, CM / Chadda, S / Chapman, R / Curry, A et al. | 2016
- A398
-
A Patient Level Simulation ModelGharibnaseri, Z. / Davari, M. / Cheraghali, A. / Eshghi, P. / Ravanbod, R. / Spendar, R. et al. | 2016
- A398
-
Systematic Review ToolboxMarshall, C. / Sutton, A. et al. | 2016
- A398
-
A Conceptual Approach For Including Productivity Losses In Health Economic Evaluations From A Societal ViewpointMüller, M. / Hofmann, S. et al. | 2016
- A399
-
A Secure Smartphone Application For Clinical Research On Wound Healing: NurstrialAllaert, F. et al. | 2016
- A399
-
Methods For Analyzing Patient-Reported Outcomes In Oncology TrialsWilliams, P. / Fofana, F. / de la Loge, C. / Arnould, B. et al. | 2016
- A399
-
How Assessment Methods May Affect The Efficiency Of Appraisal Process: A Critical ReviewGiorgia Tedesco, G. / Francesco Faggiano, F. / Andellini, M. / Leo, E. / Losito, G. / Pietro Derrico, P. / Matteo Ritrovato, M. et al. | 2016
- A399
-
Design And Operational Considerations For Hybrid Retrospective-Prospective StudiesPage, M. / Walke, H. et al. | 2016
- A399
-
Utilisation Of Survival Outcomes Data To Forecast Economic Impact Of Pricing And Market Access Scenarios In A Multi-Indication Patient Flow ModelsSogokon, P. / Hunt, M. / Kjeldgaard-Pedersen, J. / Furneri, G. / Chalmers, M. et al. | 2016
- A399
-
Value And Cost Conundrum In Advanced Oncology: Integration Of Value Frameworks Into Cost-Effectiveness AnalyesAmbavane, A. / Benedict, A. / Lanitis, T. / Kongnakorn, T. et al. | 2016
- A400
-
Determination Of Clinical And Cost-Effectiveness Of Various Methods Of Predicting Preterm Birth In Women With High RiskTuletova, A. / Dochshanova, A. et al. | 2016
- A400
-
The Public Health Perspective Of An Investigational Herpes Zoster Vaccine In The United Kingdom (Uk)van Oorschot, D. / Hunjan, M. / Varghese, L. / Canavan, C. / Curran, D. et al. | 2016
- A400
-
Effect Of A Multifactorial, Interdisciplinary Intervention On Falls And Fall Rate Of The Older People In The CommunityLee, S. / Kim, H. et al. | 2016
- A400
-
Association Between Exposure To Anticholinergic And Sedative Drugs And Healthcare Costs In Elderly Patients With Cognitive ComplaintGervais, F. / Dauphinot, V. / Krolak-Salmon, P. / Mouchoux, C. et al. | 2016
- A400
-
The Public Health Impact Of A New Herpes Zoster Vaccine To The German Populationvan Oorschot, DA / Anastassopoulou, A / Schlegel, K / Varghese, L / von Krempelhuber, A / Curran, D et al. | 2016
- A401
-
Iron Deficiency Anemia In Pregnant Women In France: A Prospective Cohort StudyClavel, T. / Zkik, A. / Berdeaux, G. / Auges, M. / Sanchez, C. / Harvey, T. et al. | 2016
- A401
-
Budget Impact Of Ulipristal Acetate 5mg In Pre-Operative Treatment Of Uterine Fibroids: An Analysis Based On Public Data On Hospital Stays In FranceTrancart, M. / Lehmann, M. / Lafuma, A. et al. | 2016
- A401
-
The Prevalence Of Sexual Dysfunctions Among Hungarian MenPalancsa, M. / Damásdi, M. / Gitta, S. / Tardi, P. / Járomi, M. / Ács, P. / Boncz, I. / Hock, M. et al. | 2016
- A401
-
Economic Evaluation Of Rfsh And Hp-Hmg For Infertility Treatment In BrazilSouza, P. / Simões, A. / Zanini, F. / Sato, C. et al. | 2016
- A401
-
Availability And Costs Of Pediatric Formulations In India : A Case StudyTayal, H. / Roy, V. et al. | 2016
- A401
-
Budget-Impact Analysis (Bia) Of The Introduction Of 52mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) As A Contraceptive Method Option In The Brazilian Public Healthcare System (Sus) To Avoid Unintended Pregnancy (Up) In 15 To 19 Year-Old AdolescentsRamos, N. / Honda, A. / Sakagute, M. / Nakada, C. / Tobaruella, F. et al. | 2016
- A402
-
Cost-Effectiveness Analysis Of 52 Mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) Versus Short-Acting Hormonal Contraceptives In Avoiding Unintended Pregnancy (Up) In 15 To 19 Year-Old Adolescents Under The Brazilian Public Healthcare System (Sus)Honda, A. / Ramos, N. / Sakagute, M. / Nakada, C. / Tobaruella, F. et al. | 2016
- A402
-
Analysis Of Real Data For Treatment Of Nausea And Vomiting Of Pregnancy (Nvp) In UkraineMaksymovych, N. / Zalis'ka, O. / Brezden, O. et al. | 2016
- A402
-
Cost Implications Of Inappropriate Prescribing Of Anti-Malarial Therapy For Treatment Of Undifferentiated Febrile Illness Among ElderlyMenon, V. / Ramesh, M. / Pereira, P. / CR, V. / Undela, K. et al. | 2016
- A402
-
Evaluating The Economic Impact Of Potentially Inappropriate Prescribing In Older People In Ireland Using A Markov Modelling ApproachMoriarty, F. / Bennett, K. / Cahir, C. / Fahey, T. et al. | 2016
- A402
-
Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In PortugalSilverio, N. / Botica, F. / Batista, A. et al. | 2016
- A402
-
Infertility Treatment Of Women Over Age 35 In Brazil: An Economic Evaluation Of Recombinant VS. Urinary GonadotropinsSouza, P. / Simões, A. / Zanini, F. / Sato, C. et al. | 2016
- A403
-
Cost‐Utility Analysis Of Ulipristal Acetate (5 Mg) For Long-Term Treatment Of Moderate To Severe Symptoms Of Uterine Fibroids In PortugalPaquete, A. / Lehmann, M. / Silva, D. / Pinto, C. et al. | 2016
- A403
-
Cost-Effectiveness Analysis Of Laparoscopic Surgery For Presumed LeiomyomasLin, Y. / Lang, H. / Tsai, Y. et al. | 2016
- A403
-
Cost Minimisation Analysis Of Follitropin Delta Versus Follitropin Alfa In Assisted Reproductive Technologies (Ivf/Icsi) In The United KingdomSivignon, M. / Palencia, R. / Roze, S. et al. | 2016
- A403
-
Clinical And Economic Analysis Of Two Surfactants For The Prevention And Treatment Of Respiratory Distress SyndromeKrasnova, L. / Vorobiev, P. / Tyurina, I. et al. | 2016
- A403
-
Vaginal Birth After Caesarean Versus Elective Repeat Caesarean Delivery In Four European Countries: A Cost-Utility AnalysisFobelets, M. / Beeckman, K. / Faron, G. / Putman, K. et al. | 2016
- A403
-
The Impact On Societal Burden Of Changed Uptake Of Hormonal TreatmentsWiden, J / Hallberg, S / Bobula, J / Moffatt, M / Borgstrom, F et al. | 2016
- A404
-
Willingness To Pay For Primary Dysmenorrhea Health StatesRuzsa, G. / Gulacsi, L. / Brodszky, V. / Péntek, M. / Gradvohl, E. / Rencz, F. et al. | 2016
- A404
-
Translation And Validation Of Condition-Specific Quality Of Life Pfdi-20 And Pfiq-7 Questionnaires For Women With Pelvic Floor Dysfunction In The Norwegian ContextTeig, C. / Bond, M. / Cvancarova, M. / Engh, M. / Kjøllesdal, M. / Øresland, T. / Saga, S. / Martini, A. et al. | 2016
- A404
-
A Review Of Patient-Reported Outcome Measures To Assess Infertility-Related Quality Of LifeKitchen, H. / Aldhouse, N. / Trigg, A. / Palencia, R. / Mitchell, S. et al. | 2016
- A404
-
Comparison Between Eq-5d And Hui In Japanese Population NormsNoto, S. / Izumi, R. / Moriwaki, K. / Shiroiwa, T. / Igarashi, A. / Fukuda, T. / Ikeda, S. / Saito, S. / Shimozuma, K. / Ishida, H. et al. | 2016
- A404
-
Self-Efficacy And Health Behaviors Impact Quality Of Life Of Elderly Along Eastern Sea Coast Of Thailand 2015Auamnoy, T. / Onnim, P. / Suriyong, P. / Dechrat, P. et al. | 2016
- A404
-
Rescaling The Overall Score In The Cervantes Short-Form Scale For Measuring Health-Related Quality Of Life In Menopausal Women Sexually InactiveCoronado, P. / Sánchez-Borrego, R. / Ruiz, M. / Rejas, J. / Collaborative Group, C. et al. | 2016
- A405
-
Use, Belief, and Risk Awerness to Medication Among Pregnant Women Attending Antenatal Care Unit at University of Gondar Teaching Hospital, Northwestethiopia: Crosssectional StudyTefera, Y. / Admasu, S. et al. | 2016
- A405
-
Irrational Use of Antibiotics in TurkeyMalhan, S. / Numanoglu Tekin, R. / Oksuz, E. et al. | 2016
- A405
-
Analysis of Antibiotics’ Use in the Treatment of Tonsillopharyngitis in Children Population of Nis DistrictKrajnovic, D. / Arsic, J. / Milijic, S. / Milosević Georgiev, A. et al. | 2016
- A405
-
Kangaroo Mother Care- A Cost Effective and an Alternate Method to Manage Hypothermia in Low Birth Weight Babies for Better Clinical OutcomeKanodia, P. / Bora, R. / Gupta, A. et al. | 2016
- A405
-
Assessing Real Consumption of Medications for Fertility Treatments in UkrainePiniazhko, O. / Zalis'ka, O. / Vons, B. / Pyrohova, V. / Malachynska, M. / Veresnyuk, N. et al. | 2016
- A406
-
Assessment of the Costs of Overall Children Vaccination with Antirotavirus Vaccine in UkraineNemchenko, A. / Podgaina, M. / Balynska, M. et al. | 2016
- A406
-
Prevalence of Potentially Inappropriate Prescribing in Central Nervous System and Psychotropic Drugs for the Korean Elderly: A Cross-Sectional Study Using the National Health Insurance Claims DatabaseCho, H. / Choi, J. / Kang, H. et al. | 2016
- A406
-
The Chickenpox Complications and Financial Burden in Healthy Children and with Underlying a Comorbidity During the Pre Vaccine and Post Vaccine Era in a University HospitalBüyükcam, A / Çelik, M / Ceyhan, M / Kara, A et al. | 2016
- A406
-
Long Term Outcome of Couples Undertaking their First IVF/ICSI Attempt: A French StudyParneix, I. / Arvis, P. / Paillet, S. / Longin, J. / Lehert, P. / Avril, C. / Lesourd, F. et al. | 2016
- A406
-
Cyproterone/Ethinylestradiol Use and Indications in the NetherlandsBezemer, I. / Smits, L. / Penning-van Beest, F. / Asiimwe, A. / Herings, R. et al. | 2016
- A406
-
Cyproterone/Ethinylestradiol and Concomitant Use of other Hormonal Contraceptives in the NetherlandsBezemer, I. / Smits, L. / Penning-van Beest, F. / Asiimwe, A. / Herings, R. et al. | 2016
- A407
-
Zinforo (Ceftaroline Fosamil) Versus other Empiric Antibiotics for Moderate-to-Severe Community Acquired Pneumonia (CAP) In Adults: a Network Meta-AnalysisRao, N / Gibson, E / Lawson, RW / Goodall, JJ et al. | 2016
- A407
-
Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy: Multicenter Cohort StudyLee, N. / Son, S. / Park, J. / Park, D. et al. | 2016
- A407
-
Translation of the UK Paediatric Influenza Primary School Vaccination Programme to 13 European Countries Using a Dynamic Transmission ModelGerlier, L. / Hackett, J. / Lawson, R. / Dos Santos Mendes, S. / Eichner, M. et al. | 2016
- A407
-
Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Definitive Therapy: A Systematic Review and Meta-AnalysisSon, S. / Lee, N. / Park, J. / Park, D. et al. | 2016
- A407
-
Comorbidities in HIV-1: A Literature Review of the Associations Between Patient- and Disease-Related Factors and Non-Aids Related Comorbidities (NARCS)Bunting, C. / Eddowes, L. / Buchanan-Hughes, A. / Steeves, S. / Perard, R. / Hay, P. et al. | 2016
- A408
-
Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in FranceUhart, M. / Largeron, N. / Drury, R. / Soubeyrand, B. et al. | 2016
- A408
-
Susceptibility Pattern of Pseudomonas Aeruginosa Isolates to Carbapenem AntibioticsZubair, M. / Hussain, T. et al. | 2016
- A408
-
Why is the Herd Protection Level Higher in the UK than in Belgium after the Introduction of the Rotavirus Vaccine?Standaert, B / Schecroun, N / Lorenc, S et al. | 2016
- A408
-
Therapeutic Indication of Lyophilized Hydrocortisone to the Treatment of Trichinosis with Neurological and / or Myocardial InvolvementZanghelini, F. / Rego, M. / Oliveira, M. / Andrade, C. / Pereira, M. / Nunes, T. / Galdino-Pitta, M. / Viana, D. / Cardoso, P. / Pitta, M. et al. | 2016
- A408
-
Zinforo (Ceftaroline Fosamil) Versus other Empiric Initial IV Antibiotics for Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-AnalysisRao, N. / Gibson, E. / Lawson, R. / Goodall, J. et al. | 2016
- A408
-
Hepatitis C – Real World Effectiveness of HCV Treatment in PolandPlisko, R. / Wladysiuk, M. / Miazga, P. / Bebrysz, M. et al. | 2016
- A409
-
Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian SettingBarbieri, M. / Crocchiolo, D. / Veneziano, M. et al. | 2016
- A409
-
Managing Healthcare Resources: Estimated Budget Impact On The National Health Service (England) Of Introduction Of Antimicrobial SuturesEdmiston, C. / Holy, C. / Leaper, D. et al. | 2016
- A409
-
Burden of Medically Attended Acute Gastroenteritis in England: A Cohort Study in CPRDFerreira, G. / Lopman, B. / Tam, C. / Harris, J. / Bollaerts, K. / Cattaert, T. / Riera, M. / Vestraeten, T. et al. | 2016
- A409
-
Prediction of the Morbidity with Bacterial Purulent Meningitis of Various Origin with Consideration of the Existing Vaccine Prevention ProceduresRyazhenov, V. / Gorokhova, S. et al. | 2016
- A409
-
Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5Gueron, B. / Nalpas, C. / Maiese, B. / Cadarette, S. / Campbell, D. / Arvin-berod, C. / Duchesne, I. et al. | 2016
- A410
-
Cost Analysis Of Raltegravir Versus Atazanavir/R Or Darunavir/R For Treatment-Naive Adults With Hiv-1 Infection In SpainDavis, A. / Brogan, A. / Goodwin, B. / Nocea, G. / Lozano, V. et al. | 2016
- A410
-
Cost Analysis Of Comorbities: Evidence From A Hiv+ Patients CohortFoglia, E / Ferrario, L / Garagiola, E / Rizzardini, G / Meraviglia, P / Atzori, C / Croce, D et al. | 2016
- A410
-
Health Care Costs, Lenght Of Stay And Mortality Of Carbapenem Resistance Gram-Negative BacteremiaAykac, K. / Tanır Basaranoglu, S. / Ozsurekci, Y. / Ceyhan, M. et al. | 2016
- A410
-
Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In SloveniaDemarteau, N. / Geets, R. / Plevnik Kapun, A. et al. | 2016
- A410
-
Budget Impact Analysis Of The Introduction Of Darunavir 800 Mg Qd For The 2nd Line Treatment Of Hiv-Infected Treatment-Experienced Adults On The Brazilian National Hiv ProgramFerreira, K. / Neves, J. / Asano, E. / Magno, L. / Loureiro, R. et al. | 2016
- A410
-
Budget Impact Analysis Of Including A Pentavalent (Hib-Hbv-Dtp) Vaccine In The National Childhood Immunization Schedule Of IranTeimouri, F. / Nikfar, S. / Kebriaeezadeh, A. et al. | 2016
- A411
-
Burden Of Comorbidities In Hcv And Hiv/Hcv Patients. Real world evidence from italian administrative databasesPerrone, V. / Sangiorgi, D. / Crovato, E. / Buda, S. / Degli Esposti, L. et al. | 2016
- A411
-
Determination Of The Vaccine-Preventable Diseases Burden In Turkey In Terms Of Various Vaccination PoliciesCeyhan, M. / Bayhan, C. / Ozsurekci, Y. / Malhan, S. / Numanoglu Tekin, R. / Mcintosh, D. et al. | 2016
- A411
-
Indirect Cost Of Hiv/Aids: Results Of A Survey From A Turkish Research CenterTatar, M. / Kockaya, G. / Ozelgun, B. / Zengin Elbir, T. / Senturk, A. / Tuna, E. / Unal, S. / Tumer, A. / Inkaya, C. et al. | 2016
- A411
-
Health Resources Use In Patients With Human Immunodeficiency Virus (Hiv) Infection. Real world evidence from italian administrative databasesPerrone, V. / Sangiorgi, D. / Crovato, E. / Buda, S. / Degli Esposti, L. et al. | 2016
- A411
-
Direct Cost Of Hiv/Aids In TurkeyTatar, M / Kockaya, G / Ozelgun, B / Zengin Elbir, T / Senturk, A / Tuna, E / Unal, S / Tumer, A / Inkaya, C et al. | 2016
- A411
-
Complications And Health Care Costs Of Influenza In Germany: A Retrospective Claims Data AnalysisScholz, S. / Damm, O. / Ultsch, B. / Schneider, U. / Remschmidt, C. / Weidemann, F. / Wichmann, O. / Greiner, W. et al. | 2016
- A412
-
Cost Assessment Of Antibiotics Use In A Hospital In The Dominican RepublicMouly, M. / Puello Guerrero, A. / Dumartin, C. / Silva, M. / Aulois-Griot, M. et al. | 2016
- A412
-
Clinical And Econimic Burden Of Community-Onset Complicated Skin And Skin Structure Infection (Csssi) In KoreaLee, M. / Kim, Y. / Cho, Y. et al. | 2016
- A412
-
What Is The Hospital Economic Burden Of Hiv In France? Results from an analysis of the national french medical information system databaseYazdanpanah, Y. / Bonnet, F. / de Léotoing, L. / Finkielsztejn, L. / Chaize, G. / Vainchtock, A. / Nachbaur, G. / Aubin, C. et al. | 2016
- A412
-
Patient Characteristics And Outcomes Of Hospitalization For Influenza Infection In Hong KongChan, Y / Lee, N / You, J et al. | 2016
- A412
-
Evaluation Of The Clinical Characteristics And Economic Burden Of United States Veteran Patients Diagnosed With The Hepatitis C VirusWang, L. / Li, L. / Zhou, X. / Pandya, S. / Baser, O. et al. | 2016
- A413
-
The Public Health And Economic Impact Of Gender Neutral Quadrivalent Human Papillomavirus Vaccination Program In BrazilCoutinho, M. / Serra, F. / Monsanto, H. / Kulkarni, A. / Pavelyev, A. et al. | 2016
- A413
-
Cost-Effectiveness Analysis Of Highly Innovative Treatments For Hepatitis C: The Case Of Ledipasvir/Sofosbuvir In A Greek Healthcare SettingAthanasakis, K / Boubouchairopoulou, N / Kyriopoulos, I / Tsoulas, C / Tzanakis, B / Kyriopoulos, J et al. | 2016
- A413
-
Universal Mass Vaccination With Phid-Cv Is Cost-Effective In CroatiaBencina, G. / Olbrecht, J. et al. | 2016
- A413
-
Clinical And Economic Outcomes Of Patients Hospitalized For Herpes Zoster In Hong KongYu, W. / Chan, P. / You, J. et al. | 2016
- A413
-
Determining The Clinical Practice And Resource Use Associated To The Diagnosis And Treatment Of Clostridium Difficile Infection In MexicoPérez Bolde-Villarreal, C. / Pastor-Martínez, V. / reyes-Lopez, A. / Jimenez-Juarez, R. et al. | 2016
- A413
-
Assessing The Consequences Of Sustained Off-Therapy Hbsag Loss In Health Economic Models Of Chronic Hepatitis B; A Systematic Literature ReviewHashim, M. / Cerri, K. / Sbarigia, U. / Heeg, B. et al. | 2016
- A414
-
Cost-Effectiveness Of The 13-Valent Pneumococcal Conjugate Vaccine In Adults In PortugalAlarcão, J. / Fiorentino, F. / Gouveia, M. / Jesus, G. / Costa, J. / Borges, M. et al. | 2016
- A414
-
Cost-Effective Analysis Of The Dengue Vaccine In Costa RicaXirinachs, Y et al. | 2016
- A414
-
Cost Of Dengue And Cost-Effectiveness Of The Dengue Vaccine In PanamaGarcia, L. / Cerezo, L. / Blas, A. / Alvarez, S. / Quiroz, N. / Caicedo Navas, A. / Lopez, J. / Vandeputte, C. et al. | 2016
- A414
-
Cost-Effectiveness Evaluation Of Phid-Cv Versus Pcv-13 In PolandWepsięć, K. / Stryjewska, I. / Mrozek-Gasiorowska, M. / Olbrecht, J. et al. | 2016
- A414
-
A Systematic Review Of The Cost-Effectiveness Of Quadrivalent Influenza Vaccinevan Maanen, B. / Postma, M. / de Boer, P. et al. | 2016
- A415
-
Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian FederationYagudina, R. / Kulikov, A. / Babiy, V. et al. | 2016
- A415
-
Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian FederationYagudina, R. / Kulikov, A. / Babiy, V. et al. | 2016
- A415
-
Cost-Effectiveness Analysis Of Sofosbuvir For Genotype 2 Hepatitis C In GreeceAthanasakis, K. / Boubouchairopoulou, N. / Kyriopoulos, I. / Tsoulas, C. / Tzanakis, B. / Kyriopoulos, J. et al. | 2016
- A415
-
Cost-Effectiveness Of Grazoprevir / Elbasvir In Patients With Chronic Hepatitis C VirusMattingly, T. / Slejko, J. / Mullins, C. et al. | 2016
- A415
-
Cost-Effectiveness Of Prevenar 13 In Children In PortugalFiorentino, F. / Gouveia, M. / Jesus, G. / Costa, J. / Borges, M. et al. | 2016
- A415
-
Cost Effectiveness Analysis Of Different Health Policies Based On The Second Generation Daa-Ifn Free Regimens In An Italian PopulationRuggeri, M. / Romano, F. et al. | 2016
- A416
-
Beyond Cervical Cancer: The Cost-Effectiveness Of Hpv Vaccination In The NetherlandsSetiawan, D. / Cao, Q. / Westra, T. / Postma, M. et al. | 2016
- A416
-
Inclusion Of Costs And Effects Related To Toxicity/Safety In Cost -Effectiveness Analysis; An Illustration For Influenza VaccinesFens, T. / de Boer, P. / Postma, M. et al. | 2016
- A416
-
Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In FranceSroczynski, G. / Conrads-Frank, A. / Mühlberger, N. / Kühne, F. / Jeanblanc, G. / Samp, J. / Durand-Zaleski, I. / Siebert, U. et al. | 2016
- A416
-
Economic Evaluation Of Yellow Fever Routine Vaccination In ColombiaHoestlandt, C. / Broban, A. / Houillon, G. / Caicedo, A. / Martinez, J. / Kieffer, A. et al. | 2016
- A416
-
Cost Of Dengue Illness And Cost-Effectiveness Of The Cdy-Tdv Dengue Vaccine In EcuadorLucio-Romero, R. / Henriquez-Trujillo, A. / Bermudez-Gallegos, K. / Tello-Ponce, B. / Caicedo Navas, A. / Vandeputte, C. et al. | 2016
- A417
-
Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1a Hcv In GreeceMylonas, C. / Kourlaba, G. / Vernadaki, A. / Kakouros, M. / Maniadakis, N. et al. | 2016
- A417
-
Systematic Review Of Studies Estimating The Cost-Effectiveness Of Hiv Pre-Exposure Prophylaxis (Prep) In Men Who Have Sex With Men (Msm)Damm, O. / Scholz, S. / Greiner, W. et al. | 2016
- A417
-
Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In GreeceInsinga, R. / Dalakaki, E. / Retsa, M. / Karokis, A. / Sarpong, E. et al. | 2016
- A417
-
Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1b Hcv In GreeceMylonas, C. / Kourlaba, G. / Vernadaki, A. / Kakouros, M. / Maniadakis, N. et al. | 2016
- A417
-
The Cost Of Treating Mucormycosis With Isavuconazole Compared With Liposomal Amphotericin B Followed By Posaconazole In The United Kingdom: Economic Evaluation Of The Phase Iii Vital Study And Fungiscope Matched Case-Control AnalysisKuessner, D. / Bagshaw, E. / Blackney, M. / Cornely, O. / Heimann, S. / Posthumus, J. et al. | 2016
- A417
-
Determening The Optimal Price For New Non-Nucleoside Reverse Transcritase Inhbitor Using Early Economic ModelingMusina, N. / Pogorelova, E. / Savilova, A. / Korzinov, O. et al. | 2016
- A418
-
Dengue Negatively Affects Gdp And Federal Revenues In Endemic Areas Of MexicoSamaniego, R. / Aburto, C. et al. | 2016
- A418
-
Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv): A Systematic Literature Review (Slr) Using Rapid Review MethodologyBuchanan-Hughes, A. / Eddowes, L. / Ma, Q. / Perard, R. / Hay, P. et al. | 2016
- A418
-
Effect Of Sociodemographic Determinants And Socio-Economic Status On Poliomyelitis Immunization Among Under-Five Children In PakistanIqbal, M. / Bahari, M. et al. | 2016
- A418
-
Health State Utilities Associated with Post-Surgical Staphylococcus Aureus InfectionMatza, L. / Kim, K. / Yu, H. / Belden, K. / Chen, A. / Kurd, M. / Lee, B. / Webb, J. et al. | 2016
- A418
-
Economic Evaluation Of Abbvie’s Regimen (Viekirax) For Patients With Genotype 4 Hcv In GreeceMylonas, C. / Kourlaba, G. / Vernadaki, A. / Kakouros, M. / Maniadakis, N. et al. | 2016
- A419
-
Health State Utility Values (Hsuvs) Measured Using The Euroqol 5-Dimensions (Eq-5d) Questionnaire In Adults With Chronic Hepatitis C (Chc): A Systematic Literature Review (Slr)Buchanan-Hughes, A. / Hanman, K. / Langford, B. / Eddowes, L. et al. | 2016
- A419
-
A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like IllnessDamm, O. / Scholz, S. / Ultsch, B. / Weidemann, F. / Remschmidt, C. / Wichmann, O. / Greiner, W. et al. | 2016
- A419
-
German Travelers’ Preferencences For Vaccines Against Travel-Related IllnessesPoulos, C. / Curran, D. / Anastassopoulou, A. / De Moerlooze, L. et al. | 2016
- A419
-
What Motivates Mothers To Pay For A Vaccine Against Children’s Diarrhea? Preferences for vaccines against children’s diarrheal illness among mothers in poland and hungaryPoulos, C. / Standaert, B. / Sloesen, B. / Hauber, A. et al. | 2016
- A419
-
Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life QuestionnaireJohnson, K. / Brenneman, S. / Newransky, C. / Sheffler-Collins, S. / Becker, L. / Belland, A. / Acosta, C. et al. | 2016
- A420
-
Impaired Quality Of Life After Chikungunya Virus Infection: A 12-Months Follow-Up Study Of Its Chronic Inflammatory Rheumatism In La Virginia, Risaralda, ColombiaRodriguez-Morales, AJ / Restrepo-Posada, VM / Acevedo-Escalante, N / Rodríguez-Muñoz, ED / Valencia-Marín, M / Castrillón-Spitia, JD / Londoño, JJ / Bedoya-Rendón, HD / Jd, Cárdenas-Pérez / Cardona-Ospina, JA et al. | 2016
- A420
-
Herpes Zoster And Postherpetic Neuralgia: Quality Of Life And Healthcare Utilization, A German StudyAnastassopoulou, A. / Curran, D. / Schmidt‐Ott, R. / Schutter, U. / Simon, J. / Poulsen Nautrup, B. / Matthews, S. et al. | 2016
- A420
-
Analysis Of Influenza Vaccination Effectiveness In General PractitionerLehocka, L. / Masarykova, L. / Olearova, A. / Koscova, D. et al. | 2016
- A420
-
Psychometric Validation Of Four Patient-Reported Outcome Instruments In A Diverse Sample Of Adults With Chronic Hepatitis C Virus Infection Treated With Simeprevir And SofosbuvirTrigg, A. / Kitchen, H. / Willgoss, T. / Ho, K. / Pierson, R. / Scott, J. et al. | 2016
- A420
-
Soft Modelling Of Health-Related Quality Of Life Specific To Hiv In Relation To Anxiety, Depression, Personality Traits And PrecariousnessAboromman, M. / Lalanne, C. / Dimi, S. / Carrieri, P. / Reeder, A. / Zucman, D. / Chassany, O. / Duracinsky, M. et al. | 2016
- A420
-
Psychometric Evaluation Of The Revised Hiv Treatment Satisfaction Questionnaire (Hivtsq)Romaine, J. / Murray, M. / Bradley, C. et al. | 2016
- A421
-
Impact of Dosing Schedule on the Success of A Vaccination Programme in an Elderly PopulationMatthews, I. / Dawson, H. / Préaud, E. / Lu, X. / Harrison, J. / Lee, A. et al. | 2016
- A421
-
Utilisation of Antiretrovirals in the Slovak Republic - A 10-Year Retrospective StudyOlearova, A. / Navratil, M. / Lehocka, L. / Masarykova, L. et al. | 2016
- A421
-
Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in EnglandAhir, H. / McCann, E. / Robertson, S. / Patel, S. / Yu, E. / Tham, R. et al. | 2016
- A421
-
Dispensing Patterns of Vaccines by Pharmacies in South AfricaTruter, I / Lamprecht, JC et al. | 2016
- A421
-
Seasonal Variations of Outpatient Antibiotic use in AustriaHinteregger, M. / Janzek-Hawlat, S. / Reichardt, B. et al. | 2016
- A422
-
Estimating the Value of A New Antibiotic: A Novel Approach Using Esbl As A Case StudyGeale, K / Corcoran, K / Virhage, M / Anell, B et al. | 2016
- A422
-
Direct Costs Associated to Meningococcal Disease and Related Sequelae in Children – Analysis Based on the Brazilian Public Health System PerspectiveSalgado, J. / Silva, D. / Lorenzato, F. / Cintra, O. / Saturnino, L. et al. | 2016
- A422
-
General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In FranceSilva, M. / Perrier, L. / Späth, H. / Paget, J. / Buthion, V. / Mosnier, A. / Cohen, J. / Aulois-Griot, M. et al. | 2016
- A422
-
Length of Stay, Costs and Mortality Attributable to Clostridium Difficile Infections in 13 Belgian HospitalsPirson, M. / Poirrier, J. / Joubert, S. et al. | 2016
- A422
-
Reducing disparities in u.s. Vaccination through senior centers: A Comparison of three Educational Models for Older African AmericansPrioli, K. / Schafer, J. / Pizzi, L. et al. | 2016
- A422
-
Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration TherapiesSbarigia, U. / Wirth, D. / Van Nuys, K. / Huber, C. / Brookmeyer, R. / Stahmeyer, J. / Krauth, C. et al. | 2016
- A423
-
First Results From A Retrospective Study on the Epidemiology of the Hungarian Hiv Infected PopulationKósa, F. / Takács, P. / Tronczynski, K. / Duchesne, I. / Kasza, K. / Merth, G. / Merész, G. / Rózsa, P. / Szlávik, J. et al. | 2016
- A423
-
The Potential Public Health Impact of Varicella Vaccination in HungaryMeszner, Z. / Benedek, A. / Kyle, J. / Pillsbury, M. / Wolfson, L. et al. | 2016
- A423
-
The Impact of Regional Cost-Saving Initiatives on the Uptake of Antiretroviral Drugs in LondonOhanjanyan, A. / Mukku, D. / Edathodu, A. / Samuel, J. / Leung, S. et al. | 2016
- A423
-
Public Knowledge and Attitudes Towards Zika Virus and its Prevention in MalaysiaKhan, M. / Ahmad, A. / Arief, M. / Saleem, F. / Hassali, M. / Bhagavathula, A. et al. | 2016
- A423
-
Sick Leave and Disability Pension in Patients with Chronic Hepatitis C Compared with Matched General Population Comparators: A Nationwide Population-Based Register StudyBüsch, K. / Hansson, F. / Kövamees, J. / Söderholm, J. et al. | 2016
- A424
-
Health Technology Assessment of the use Vaccines for Prevention FluVorobiev, P. / Dugin, D. / Krasnova, L. et al. | 2016
- A424
-
Economic Burden of Anti-Methicillin-Resistant Staphylococcus Aureus (Mrsa) Therapy in Public Hospitals of Paris (Ap-Hp) and Adequacy with the Defined Daily DosesTherasse, C. / Fusier, I. / Cordonnier, A. / Vittecoq, D. / Paubel, P. et al. | 2016
- A424
-
Antibiotic Utilisation and Expenditure in IrelandClarke, S. / Bennett, K. / Oza, A. / Cunney, R. / Barry, M. et al. | 2016